ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
반려동물 암 치료 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 4억 3,000만 달러에서 2026년에는 4억 8,000만 달러로, CAGR 10.3%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 반려동물의 암 발생률 증가, 기존 화학요법 프로토콜 개발, 동물병원 인프라 확충, 반려동물 진단 영상 기술 발전, 반려동물 인구 증가 등이 요인으로 꼽히고 있습니다.
반려동물 암 치료 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 CAGR 11.0%로 7억 2,000만 달러에 달할 전망입니다. 예측 기간 동안의 성장은 면역 및 표적 치료의 발전, 진단 및 치료에 인공지능의 통합, 온라인 및 소매 약국 채널의 확대, 조기 암 발견에 대한 인식 제고, 수의 종양학 연구에 대한 투자 증가에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 반려동물 암에 대한 표적 치료제 도입 증가, 반려동물의 면역요법 사용 확대, 다각적 암 치료 프로토콜의 확대, 반려동물의 조기 암 발견에 대한 관심 증가, 반려동물 종양학에서 완화의료의 통합 등을 들 수 있습니다.
반려동물의 암 발병률 증가는 향후 몇 년 동안 반려동물 암 치료 시장의 성장을 견인할 것으로 예상됩니다. 반려동물 암은 개, 고양이 등 가축화된 동물에서 세포가 비정상적으로 통제할 수 없을 정도로 증식하여 종양을 형성하는 상태를 말합니다. 반려동물의 암 발생 증가의 주요 요인은 환경독소 및 오염물질 노출과 더불어 유전적 요인 및 생활습관 요인에 기인하며, 이로 인해 반려동물을 위한 고성능의 효과적인 암 치료제에 대한 수요가 증가하고 있습니다. 반려동물 암 치료는 암세포를 표적으로 파괴하거나 종양의 성장을 늦추는 방식으로 작용하여 환자의 생존율 향상과 통증 및 불편감 감소에 기여합니다. 예를 들어, 미국수의사협회(AVMA)의 보고에 따르면 2025년까지 약 4마리 중 1마리가 평생 동안 암에 걸릴 것이며, 10세 이상의 개에서는 2마리 중 1마리가 암에 걸릴 것으로 예측하고 있습니다. 따라서 반려동물의 암 발병률 증가는 반려동물 암 치료 시장의 성장을 촉진할 것으로 예상됩니다.
반려동물 암 치료 시장의 주요 기업들은 치료 효과 향상과 암세포에 대한 표적 정확도를 높이는 후생유전학 기술 개발에 집중하고 있으며, 이를 통해 암 진단을 받은 반려동물의 예후를 개선하는 것을 궁극적으로 목표로 하고 있습니다. 후생유전학 기술은 DNA 염기서열 자체를 바꾸지 않고 유전자 발현을 조절하여 세포의 거동과 치료 결과에 영향을 미치는 기술입니다. 예를 들어, 2024년 4월, 미국에 본사를 둔 다국적 후생유전학 기업 VolitionRx Limited는 'Nu.Q Vet Cancer Test'를 발표했습니다. 이 검사는 Element i+Analyzer에서 작동하며, 보통 약 6분 정도의 짧은 시간 내에 결과를 제공합니다. 효소면역측정법을 이용하여 혈액 내 순환 뉴클레오솜을 검출하는 것으로, 이는 암의 존재를 나타내는 지표가 될 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Pet cancer therapeutics involve the use of various treatments and medications to manage or cure cancer in pets. The choice of therapeutics depends on several factors such as the type and stage of cancer, as well as the pet's age and overall health.
The main types of pet cancer therapeutics are tailored to specific cancer types, including melanoma, mast cell cancer, lymphoma, and mammary and squamous cell cancer. Melanoma is a type of cancer that originates from pigment-producing cells called melanocytes. These therapeutics can be administered through various routes, including oral and injection methods, tailored for dogs, cats, and other animals. Different therapies employed in pet cancer treatment include chemotherapy, radiation therapy, immunotherapy, tomo therapy, and others. These therapies are utilized by veterinary hospitals, clinical pharmacies, retail pharmacies, online pharmacies, and other healthcare facilities focused on pet health.
Tariffs have influenced the pet cancer therapeutics market by increasing the cost of imported oncology drugs, targeted therapy agents, and specialized diagnostic equipment, particularly impacting regions such as North America and Europe. Segments like immunotherapy and advanced radiation therapies are most affected. Positive outcomes include incentivizing domestic production of therapeutics and promoting localized research initiatives to reduce dependency on imports.
The pet cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides pet cancer therapeutics market statistics, including pet cancer therapeutics industry global market size, regional shares, competitors with a pet cancer therapeutics market share, detailed pet cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pet cancer therapeutics industry. This pet cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pet cancer therapeutics market size has grown rapidly in recent years. It will grow from $0.43 billion in 2025 to $0.48 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising incidence of cancer in companion animals, development of conventional chemotherapy protocols, increasing veterinary hospital infrastructure, advancements in diagnostic imaging for pets, growth of companion animal population.
The pet cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $0.72 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to advancements in immunotherapy and targeted therapy, integration of artificial intelligence in diagnosis and treatment, expansion of online and retail pharmacy channels, increasing awareness of early cancer detection, rising investment in veterinary oncology research. Major trends in the forecast period include rising adoption of targeted therapies for pet cancer, increasing use of immunotherapy in companion animals, expansion of multi-modal cancer treatment protocols, growing focus on early cancer detection in pets, integration of palliative care in pet oncology.
The rising prevalence of pet cancer is expected to drive the growth of the pet cancer therapeutics market in the coming years. Pet cancer refers to the abnormal and uncontrolled growth of cells in domesticated animals, such as dogs or cats, leading to tumor formation. The increase in pet cancer cases is primarily attributed to exposure to environmental toxins and pollutants, along with genetic and lifestyle factors, resulting in higher demand for advanced and effective cancer therapeutics for pets. Pet cancer therapeutics work by targeting and destroying cancer cells or slowing tumor growth, thereby improving survival outcomes and reducing pain and discomfort in affected animals. For example, in 2025, according to the American Veterinary Medical Association (AVMA), a US-based veterinary health authority, approximately 1 in 4 dogs will develop cancer during their lifetime, with the risk rising to 1 in 2 for dogs over 10 years of age. Consequently, the increasing prevalence of pet cancer is expected to fuel growth in the pet cancer therapeutics market.
Leading companies in the pet cancer therapeutics market are focusing on developing epigenetic technologies to enhance the efficacy of treatments and improve precision in targeting cancer cells, ultimately leading to better outcomes for pets diagnosed with cancer. Epigenetic technology involves techniques that modify gene expression without altering the underlying DNA sequence, thereby influencing cellular behavior and therapeutic results. For example, in April 2024, VolitionRx Limited, a US-based multinational epigenetics company, launched the Nu.Q Vet Cancer Test. This test operates on the Element i+ Analyzer and delivers rapid results-typically within approximately six minutes. It employs an enzyme-linked immunosorbent assay to detect circulating nucleosomes in the blood, which can serve as indicators of cancer presence.
In June 2024, Lantheus, a US-based company specializing in the development and commercialization of innovative imaging products and radiopharmaceuticals for diagnostic purposes in healthcare, acquired Life Molecular Imaging GmbH for an undisclosed sum. This acquisition is intended to enhance Lantheus's portfolio of diagnostic imaging solutions, expand its capabilities in molecular imaging, and strengthen its position within the healthcare market. Life Molecular Imaging GmbH, based in Germany, is dedicated to advancing imaging technologies, particularly in the realm of molecular imaging.
Major companies operating in the pet cancer therapeutics market are AB Science, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., Dechra Pharmaceuticals plc, AdvaVet Inc., Oasmia Pharmaceuticals AB, Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc., Boehringer Ingelheim GmbH, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Norbrook Laboratories Ltd., Zenoaq Co. Ltd., Morphogenesis Inc.
North America was the largest region in the pet cancer therapeutics market in 2025. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pet cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pet cancer therapeutics market consists of revenues earned by entities by surgery and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pet Cancer Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pet cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pet cancer therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pet cancer therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Cancer Type: Melanoma; Mast Cell Cancer; Lymphoma; Mammary And Squamous Cell Cancer
2) By Species: Dogs; Cats; Other Species
3) By Therapy: Chemotherapy; Radiation Therapy; Immunotherapy; Tomotherapy; Other Therapies
4) By End User: Veterinary Hospitals; Clinical Pharmacies; Retail Pharmacies; Online Pharmacies; Other End Users
Subsegments:
1) By Melanoma: Surgical Interventions; Chemotherapy; Immunotherapy; Targeted Therapy
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Rising Adoption Of Targeted Therapies For Pet Cancer
4.2.2 Increasing Use Of Immunotherapy In Companion Animals
4.2.3 Expansion Of Multi-Modal Cancer Treatment Protocols
4.2.4 Growing Focus On Early Cancer Detection In Pets
4.2.5 Integration Of Palliative Care In Pet Oncology
5. Pet Cancer Therapeutics Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Clinical Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies
5.5 Research Institutions
6. Pet Cancer Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Pet Cancer Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Pet Cancer Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Pet Cancer Therapeutics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Pet Cancer Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Pet Cancer Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Pet Cancer Therapeutics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Pet Cancer Therapeutics Market Segmentation
9.1. Global Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
9.2. Global Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Dogs, Cats, Other Species
9.3. Global Pet Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Chemotherapy, Radiation Therapy, Immunotherapy, Tomotherapy, Other Therapies
9.4. Global Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users
9.5. Global Pet Cancer Therapeutics Market, Sub-Segmentation Of Melanoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Pet Cancer Therapeutics Market, Sub-Segmentation Of Mast Cell Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Pet Cancer Therapeutics Market, Sub-Segmentation Of Mammary And Squamous Cell Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options
10. Pet Cancer Therapeutics Market Regional And Country Analysis
10.1. Global Pet Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Pet Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Pet Cancer Therapeutics Market
11.1. Asia-Pacific Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Pet Cancer Therapeutics Market
12.1. China Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Pet Cancer Therapeutics Market
13.1. India Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Pet Cancer Therapeutics Market
14.1. Japan Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Pet Cancer Therapeutics Market
15.1. Australia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Pet Cancer Therapeutics Market
16.1. Indonesia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Pet Cancer Therapeutics Market
17.1. South Korea Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Pet Cancer Therapeutics Market
18.1. Taiwan Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Pet Cancer Therapeutics Market
19.1. South East Asia Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Pet Cancer Therapeutics Market
20.1. Western Europe Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Pet Cancer Therapeutics Market
21.1. UK Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Pet Cancer Therapeutics Market
22.1. Germany Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Pet Cancer Therapeutics Market
23.1. France Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Pet Cancer Therapeutics Market
24.1. Italy Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Pet Cancer Therapeutics Market
25.1. Spain Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Pet Cancer Therapeutics Market
26.1. Eastern Europe Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Pet Cancer Therapeutics Market
27.1. Russia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Pet Cancer Therapeutics Market
28.1. North America Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Pet Cancer Therapeutics Market
29.1. USA Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Pet Cancer Therapeutics Market
30.1. Canada Pet Cancer Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Pet Cancer Therapeutics Market
31.1. South America Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Pet Cancer Therapeutics Market
32.1. Brazil Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Pet Cancer Therapeutics Market
33.1. Middle East Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Pet Cancer Therapeutics Market
34.1. Africa Pet Cancer Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Segmentation By Species, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Pet Cancer Therapeutics Market Regulatory and Investment Landscape
36. Pet Cancer Therapeutics Market Competitive Landscape And Company Profiles
36.1. Pet Cancer Therapeutics Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Pet Cancer Therapeutics Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Pet Cancer Therapeutics Market Company Profiles
36.3.1. AB Science Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.3. ELIAS Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Anivive Lifesciences Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Pet Cancer Therapeutics Market Other Major And Innovative Companies
QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., Dechra Pharmaceuticals plc, AdvaVet Inc., Oasmia Pharmaceuticals AB, Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc., Boehringer Ingelheim GmbH, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Norbrook Laboratories Ltd.
38. Global Pet Cancer Therapeutics Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Pet Cancer Therapeutics Market
40. Pet Cancer Therapeutics Market High Potential Countries, Segments and Strategies
40.1 Pet Cancer Therapeutics Market In 2030 - Countries Offering Most New Opportunities
40.2 Pet Cancer Therapeutics Market In 2030 - Segments Offering Most New Opportunities
40.3 Pet Cancer Therapeutics Market In 2030 - Growth Strategies
